LIPOSOMES ENHANCE THE IMMUNOGENICITY OF RECONSTITUTED INFLUENZA-VIRUS A/PR/8 ENVELOPES AND THE FORMATION OF PROTECTIVE ANTIBODY BY INFLUENZA-VIRUS A/SICHUAN/87 (H3N2) SURFACE-ANTIGEN

被引:15
作者
GREGORIADIS, G [1 ]
TAN, L [1 ]
BENAHMEIDA, ETS [1 ]
JENNINGS, R [1 ]
机构
[1] UNIV SHEFFIELD,SCH MED,DEPT EXPTL & CLIN MICROBIOL,SHEFFIELD S10 2RX,S YORKSHIRE,ENGLAND
基金
英国医学研究理事会;
关键词
LIPOSOMES; INFLUENZA VIRUS ANTIGENS; IMMUNOLOGICAL ADJUVANTS; VACCINES;
D O I
10.1016/0264-410X(92)90509-I
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reconstituted influenza virus (A/PR/8 strain) envelopes (RIVE) and influenza virus (A/Sichan/87 (H3N2) strain) surface antigens were entrapped in dehydration-rehydration vesicles (DRV liposomes) composed of egg phosphatidylcholine (PC) or distearoyl phosphatidylcholine (DSPC DRV) and equimolar (32-mu-mol) cholesterol. Entrapment values for RIVE were 31.2 (PC) and 29.4% (DSPC DR V) of the material used. Corresponding entrapment values for the A/Sichuan/87 strain antigens were 40.7 and 39.3%. Balb/c mice injected intramuscularly with PC or DSPC DRV liposomes containing 0.1 and 1.0-mu-g RIVE exhibited primary (higher dose only) and secondary responses (IgG1) which were significantly higher than those obtained in mice injected with identical amounts of non-entrapped RIVE. Significantly higher secondary responses were also observed for the IgG2a and IgG2b subclasses. In experiments designed to assess the effectiveness of DRV liposomes as a carrier of influenza virus antigens in a potential vaccine, hamsters were immunized intramuscularly with 0.1, 0.5 and 5.0-mu-g of free or liposome-entrapped influenza A/Sichuan/87 surface antigens. Results showed increased haemagglutination inhibition (HI) antibody levels in terms of both primary (0.5 and 5.0-mu-g doses) and secondary (all doses) responses in the sera of animals treated with the liposomal formulations. DSPC compared with PC DRV exhibited greater adjuvanticity when the lower doses of antigens were used.
引用
收藏
页码:747 / 753
页数:7
相关论文
共 35 条
  • [1] LIPOSOMES AS IMMUNOLOGICAL ADJUVANTS
    ALLISON, AC
    GREGORIADIS, G
    [J]. NATURE, 1974, 252 (5480) : 252 - 252
  • [2] EFFECTIVENESS OF LIPOSOMES AS POTENTIAL CARRIERS OF VACCINES - APPLICATIONS TO CHOLERA-TOXIN AND HUMAN MALARIA SPOROZOITE ANTIGEN
    ALVING, CR
    RICHARDS, RL
    MOSS, J
    ALVING, LI
    CLEMENTS, JD
    SHIBA, T
    KOTANI, S
    WIRTZ, RA
    HOCKMEYER, WT
    [J]. VACCINE, 1986, 4 (03) : 166 - 172
  • [3] [Anonymous], 1988, LIPOSOMES DRUG CARRI
  • [4] BAKOUCHE O, 1986, IMMUNOLOGY, V57, P219
  • [5] LIPOSOMES AS ADJUVANTS WITH IMMUNOPURIFIED TETANUS TOXOID - THE IMMUNE-RESPONSE
    DAVIS, D
    DAVIES, A
    GREGORIADIS, G
    [J]. IMMUNOLOGY LETTERS, 1987, 14 (04) : 341 - 348
  • [6] DAVIS D, 1987, IMMUNOLOGY, V61, P229
  • [7] DAVIS D, 1989, IMMUNOLOGY, V68, P277
  • [8] IMMUNIZATION AGAINST EXPERIMENTAL MURINE SALMONELLOSIS WITH LIPOSOME-ASSOCIATED O-ANTIGEN
    DESIDERIO, JV
    CAMPBELL, SG
    [J]. INFECTION AND IMMUNITY, 1985, 48 (03) : 658 - 663
  • [9] INTRANASAL IMMUNIZATION WITH PROTEOLIPOSOMES PROTECTS AGAINST INFLUENZA
    ELGUINK, N
    KRIS, RM
    GOODMANSNITKOFF, G
    SMALL, PA
    MANNINO, RJ
    [J]. VACCINE, 1989, 7 (02) : 147 - 151
  • [10] PROTECTION OF COTTONTOP TAMARINS AGAINST EPSTEIN-BARR VIRUS-INDUCED MALIGNANT-LYMPHOMA BY A PROTOTYPE SUBUNIT VACCINE
    EPSTEIN, MA
    MORGAN, AJ
    FINERTY, S
    RANDLE, BJ
    KIRKWOOD, JK
    [J]. NATURE, 1985, 318 (6043) : 287 - 289